Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study published online Jan. 8 in Diabetes Care.
Ali Ardestani, MD, from Brigham and Women's Hospital in Boston, and colleagues examined changes in insulin treatment after bariatric surgery in a cohort of 5,225 patients with I-T2D. RYGB was compared with laparoscopic adjustable gastric banding (LAGB). To control for differences in weight-loss patterns between the two types of bariatric surgery, the authors conducted a case-matched analysis.
http://www.hcplive.com/articles/Roux-en-Y-Surgery-Can-Reverse-Insulin-Treatment-in-Type-2-Diabetes
Ali Ardestani, MD, from Brigham and Women's Hospital in Boston, and colleagues examined changes in insulin treatment after bariatric surgery in a cohort of 5,225 patients with I-T2D. RYGB was compared with laparoscopic adjustable gastric banding (LAGB). To control for differences in weight-loss patterns between the two types of bariatric surgery, the authors conducted a case-matched analysis.
http://www.hcplive.com/articles/Roux-en-Y-Surgery-Can-Reverse-Insulin-Treatment-in-Type-2-Diabetes